Company: GRRR
Filing Date: 2025-07-02
Form Type: 424B5
Source: 0001213900-25-060827
Chunk: 6

Company: Gorilla Technology Group Inc.
Filing Date: 2025-07-02
Form: 424B5
Chunk 6
---
 the exemptions available to us as a foreign private issuer during and after the period we qualify as an emerging growth company. As a foreign private issuer, we are permitted to comply with Cayman Islands corporate governance practices instead of the Nasdaq requirements, provided that we disclose those Nasdaq requirements with which we do not comply and the equivalent Cayman Islands requirement that we follow instead (if applicable). We intend to follow home country practice in lieu of Nasdaq corporate governance requirements with respect to the following Nasdaq requirements:

| ● | Executive                                                                                                                              
 Sessions. We are not required to and, in reliance on home country practice, we may not, comply with certain Nasdaq rules               
 requiring our independent directors to meet in regularly scheduled executive sessions at which only independent directors are present. 
 We will follow Cayman Islands practice which does not require independent directors to meet regularly in executive sessions separate   
 from the full board of directors.                                                                                                      |

| ● | Proxy                                                                                                                                   
 Statements. We are not required to and, in reliance on home country practice, we may not, comply with certain Nasdaq rules              
 regarding the provision of proxy statements for general meetings of shareholders. We will follow Cayman Islands practice which does not 
 impose a regulatory regime for the solicitation of proxies.                                                                             |

| ● | Shareholder                                                                                                                              
 Approval. We are not required to and, in reliance on home country practice, we do not intend to, comply with certain Nasdaq              
 rules regarding shareholder approval for certain issuances of securities under Nasdaq Rule 5635. In accordance with the                  
 provisions of our Amended and Restated Memorandum and Articles of Association, our board of directors is authorized to issue securities, 
 including ordinary shares, preference shares, warrants and convertible notes.                                                            |

<div align='center'>S-2</div>

The Offering

| Securities offered by us                              |     | 2,529,946 ordinary shares. We are also offering pre-funded warrants to purchase 3,470,054 ordinary shares. The purchase price of each pre-funded warrant is equal to the price per share at which the ordinary shares are being sold in this offering, minus $0.0001, and the exercise price of each pre-funded warrant is $0.0001 per share. Each pre-funded warrant is exercisable at any time after the date of execution, subject to an ownership limitation. See “Description of Pre-Funded Warrants.” This prospectus supplement also relates to the offering of the ordinary shares issuable upon exercise of the pre-funded warrants.